Sana Biotechnology, Inc.
SANA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $33,230 | $40,023 | $39,146 | $33,589 |
| G&A Expenses | $10,285 | $10,341 | $11,484 | $17,277 |
| SG&A Expenses | $10,285 | $10,341 | $11,484 | $17,277 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $44,611 | $0 | $0 |
| Operating Expenses | $43,515 | $94,975 | $50,630 | $50,866 |
| Operating Income | -$43,515 | -$94,975 | -$50,630 | -$50,866 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,363 | $1,175 | $1,241 | $1,797 |
| Pre-Tax Income | -$42,152 | -$93,800 | -$49,389 | -$49,069 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$42,152 | -$93,800 | -$49,389 | -$49,069 |
| % Margin | – | – | – | – |
| EPS | -0.16 | -0.39 | -0.21 | -0.21 |
| % Growth | 59% | -85.7% | 0% | – |
| EPS Diluted | -0.16 | -0.39 | -0.21 | -0.21 |
| Weighted Avg Shares Out | 260,494 | 238,409 | 237,578 | 236,299 |
| Weighted Avg Shares Out Dil | 260,494 | 238,409 | 237,578 | 236,299 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $577 | $992 | $1,656 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $3,191 | $2,857 | $3,649 | $5,693 |
| EBITDA | -$38,961 | -$47,507 | -$46,981 | -$45,173 |
| % Margin | – | – | – | – |